Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy

There are no data comparing the efficacy and safety of prophylactic entecavir (ETV), tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) for HBV-infected cancer patients undergoing chemotherapy. This study aimed to compare the efficacy and renal safety of ETV, TDF and TAF in this set...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, I-Cheng, Lan, Keng-Hsin, Su, Chien-Wei, Li, Chung-Pin, Chao, Yee, Lin, Han-Chieh, Hou, Ming-Chih, Huang, Yi-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569539/
https://www.ncbi.nlm.nih.gov/pubmed/36232631
http://dx.doi.org/10.3390/ijms231911335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569539/
https://www.ncbi.nlm.nih.gov/pubmed/36232631
http://dx.doi.org/10.3390/ijms231911335

Ejemplares similares